Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease

Recruiting now

Conditions studied: Crohn Disease, Inflammatory Bowel Diseases, Crohn Disease of Small Intestine, Crohn Colitis, Crohn's Ileocolitis, Crohn Disease in Remission

In brief

This is an observational, single center, imaging study. The CD patients with active disease will be assessed by \[68Ga\]Ga-DOTA-Siglec-9 and \[15O\]H2O PET/MRE. Patients with high clinical suspicion of small intestine's CD in outpatient gastroenterology clinic of Turku University Hospital will be recruited. The patients must fulfil the eligibility criteria and give their signed approvement prior to their enrolment into the study. 20 patients with high suspicion of active small bowels CD will be enrolled to being evaluated for potential participation in this study. In patients with diagnosed small bowels CD, PET-MRE will be repeated 3 months after the initial imaging (and based on clinical diagnostic started medication) to verify disease remission/inadequacy of the treatment. Assessments for CD clinical disease activity will be performed at screening and \[68Ga\]Ga-DOTA-Siglec-9 and \[15O\]H2O PET/MRE assessments will be performed within a month for each patient. After PET/MRE all patients can be treated according to patients' needs with immunosuppressive drugs. Follow-up visits are organized at after PET/MRE imaging at gastroenterology outpatient clinic.

Key facts

Study ID

NCT06555042

Run by

Turku University Hospital

People needed

20

Starts

2024-09-01

Expected to finish

2026-06-06

Last updated by the study team

2024-08-15

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults between age 18-70
• Strong clinical suspicion of small bowel Crohn's disease
• Able and willing to give written informed consent and to comply with the study protocol

You may not qualify if…

• Pregnant or breast-feeding women
• Previous capsule retention
• X-ray investigations during preceding year
• Patients with metallic implants such as an electronic pacemaker or an implanted infusion pump
• Known stenosis of the GI-tract
• Evidence of significant uncontrolled concomitant diseases such as neurological, renal, hepatic, endocrine, or gastrointestinal disorders which, in the opinion of the Investigator, would preclude patient participation
• Is unable or unwilling to comply with the study protocol for any reason

Where it is running

• Turku PET Centre — Turku, Southwest Finland, Finland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.